Positive Report for Genmab (GMAB) from William Blair
Genmab (GMAB – Research Report) received a Buy rating and price target from William Blair analyst Matt Phipps today. The company’s shares ...
Genmab A/S (GMAB): Among the Stocks That Will Go to the Moon According to Analysts
We recently compiled a list of the 15 Stocks That Will Go to The Moon According to Analysts. In this article, we are going to ...
Nasdaq3d
GMAB Makes Bullish Cross Above Critical Moving Average
In trading on Friday, shares of Genmab A/S (Symbol: GMAB) crossed above their 200 day moving average of $24.14, changing hands as high as $24.32 per share. Genmab A/S shares are currently trading ...
Morgan Stanley Reaffirms Their Hold Rating on Genmab (GMAB)
Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Genmab (GMAB – Research Report) today and set a price target of $31.00. The ...
Is Genmab (GMAB) One of the Best Growth Stocks to Invest In According to Analysts?
We recently published a list of 12 Best Growth Stocks to Invest In According to Analysts. In this article, we are going to ...
Is Genmab A/S (GMAB) the Best Cash-Rich Undervalued Stock to Invest In?
We recently compiled a list of the 10 Cash-Rich Undervalued Stocks To Invest In. In this article, we are going to take a look ...
Morningstar6d
Genmab AS ADR GMAB
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Insider Monkey1mon
Why Genmab A/S (GMAB) Is Among the Best Healthcare Stocks To Buy According to Analysts
In this article, we are going to take a look at where Genmab A/S (NASDAQ:GMAB) stands against the other healthcare stocks. McKinsey reported that, since 2019, the US healthcare industry witnessed ...